Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • imrev
    Junior Member
    • Aug 2011
    • 1

    #1

    Bioinformatician for the analysis of NGS data - Helsinki, Finland

    The Institute for Molecular Medicine Finland (FIMM) has state-of-the-art Illumina DNA sequencers and is a primary site for cutting-edge ”next-gen” sequencing in Finland. For example, FIMM has sequenced over 200 human exomes. We are looking for a bioinformatician to further develop analysis and data mining capabilities for exciting projects utilising high throughput sequencing. Many of the collaborative projects aim at identifying disease-causing genetic changes, with some directly aiming at helping physicians to more accurately diagnose and better treat the disease of a patient. The post offers ample opportunities to collaborate with different research groups as well as possibilities to advance research career, such as authorship in publications. FIMM has altogether over 25 bioinformaticians and IT professionals, providing critical mass, significant expertise and support as well as an extensive international collaboration network.

    Qualification and experience
    • University degree, preferrably PhD (or DTech) and/or practical experience in bioinformatics in the academia and industry is valued
    • Experience in analyzing “next-gen” sequence data and knowledge of relevant tools is appreciated
    • Experience in gene expression analysis and knowledge of relevant tools, particularly the Bioconductor framework
    • Proficiency in Perl or Python and and working knowledge of R
    • Knowledge of Unix or Linux environment and shell scripting
    • Fluency in English and good inter-personal skills


    Terms
    The salary is in the range of €36-54k per annum depending on the qualification and experience. The contract offered will be until the end of 2013 but is extendable depending on the funding available at the time.

    How to apply
    Please apply on-line at http://www.fimm.fi/en/open_positions...informatician/.

    For further information please contact Imre Västrik at +358-504154451 or [email protected].

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
72 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...